-
公开(公告)号:US20250026782A1
公开(公告)日:2025-01-23
申请号:US18752309
申请日:2024-06-24
Applicant: Wisconsin Alumni Research Foundation
Inventor: Samuel Helmer Gellman , Rylie Kathleen Morris , Kyle Alexander Brown
IPC: C07K1/00 , A61K38/00 , C07K14/605
Abstract: Compounds, method of making the compounds, and methods of using the compounds to treat Type 2 diabetes and obesity in mammals, including humans. The compounds are dual GLP-1 receptor and GIP receptor agonists in which at least one side chain of a residue in GLP-1 and/or GIP is modified such that the modified GLP-1 and GIP are agonists of both GLP-1 receptor and GIP receptor.